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Abstract
Background: Bacterial vaginosis (BV) is a polymicrobial syndrome characterized by a change in vaginal flora away
from predominantly Lactobacillus species. The cause of BV is unknown, but the condition has been implicated in
diverse medical outcomes. The bacterium Atopobium vaginae has been recognized only recently. It is not readily
identified by commercial diagnostic kits. Its clinical significance is unknown but it has recently been isolated from
a tuboovarian abcess.
Methods: Nucleotide sequencing of PCR amplified 16S rRNA gene segments, that were separated into bands
within lanes on polyacrylamide gels by denaturing gradient gel electrophoresis (DGGE), was used to examine
bacterial vaginal flora in 46 patients clinically described as having normal (Lactobacillus spp. predominant; Nugent
score ≤ 3) and abnormal flora (Nugent score ≥ 4). These women ranged in age from 14 to 48 and 82% were
African American.
Results: The DGGE banding patterns of normal and BV-positive patients were recognizably distinct. Those of
normal patients contained 1 to 4 bands that were focused in the centre region of the gel lane, while those of BV
positive patients contained bands that were not all focused in the center region of the gel lane. More detailed
analysis of patterns revealed that bands identified as Atopobium vaginae were present in a majority (12/22) of BV
positive patients, while corresponding bands were rare (2/24) in normal patients. (P < 0.001) Two A. vaginae
isolates were cultivated from two patients whose DGGE analyses indicated the presence of this organism. Two
A. vaginae 16S rRNA gene sequences were identified among the clinical isolates. The same two sequences were
obtained from DGGE bands of the corresponding vaginal flora. The sequences differed by one nucleotide over
the short (~300 bp) segment used for DGGE analysis and migrated to slightly different points in denaturing
gradient gels. Both isolates were strict anaerobes and highly metronidazole resistant.
Conclusion: The results suggest that A. vaginae may be an important component of the complex bacterial
ecology that constitutes abnormal vaginal flora. This organism could play a role in treatment failure if further
studies confirm it is consistently metronidozole resistant.
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Bacterial vaginosis (BV) is a syndrome that appears to rep-
resent a disturbance of the vaginal ecosystem associated
with a shift in the microflora [1,2]. Several adverse medi-
cal outcomes have been associated with BV [3-11]. While
the cause of BV is not understood, some strong associa-
tions have been made between the syndrome and the
presence of particular bacterial species, such as Gardnerella
vaginalis and Prevotella sp. [2,12]. Most of these, however,
represent bacteria that have been detected by cultivation
and identified by traditional morphological and bio-
chemical methods.
Cultivation-independent (molecular) analyses, most
notably sequencing of 16S rRNA genes PCR-amplified
from microbial community DNA, offer a more systematic
approach to detecting microbes in natural habitats [13]
and a more concrete method of identification and classi-
fication [14,15]. Molecular surveys of microbes in envi-
ronmental samples have repeatedly shown that cultivated
species do not represent the full complement of microbes
in most habitats [16] and molecular analyses are now
commonly used to survey bacterial flora in mammalian
systems [17,18].
One technique, denaturing gradient gel electrophoresis
(DGGE) analysis of PCR-amplified 16S rRNA gene seg-
ments, offers the possibility of revealing a significant por-
tion of the bacterial flora in a sample as a pattern of bands
on an acrylamide gel [19,20]. The bands are separated
based on their denaturing characteristics, i.e. sequences
and the sequences of individual bands can be obtained
allowing the identification of bacteria in the sample.
DGGE patterns have been used to reveal changes in micro-
flora and to identify microbes in a variety of habitats [20-
26] including human vaginal flora [12,27,28] and other
mammalian systems [29-32].
In the course of DGGE analyses of vaginal bacterial flora
of normal and BV-positive patients, we detected a band
whose sequence matched that of Atopobium vaginae (Gen-
Bank reference no. AF325325 and American Type Culture
Collection [ATCC] #BAA 55) in 55% of BV positive
patients. A. vaginae is a recently recognized species [33]
whose clinical significance is unknown, though it has
been identified recently as the cause of a tuboovarian
abscess [34]. The isolate described in this case report was
found to be highly resistant to metronidazole. We isolated
two A. vaginae strains from BV patients. Antibiotic suscep-
tibility studies were performed using these two strains and




Subjects participated in two different protocols in two
locations. In Indianapolis, adolescent females attending
one of three adolescent health clinics were enrolled in a
prospective cohort study of risk factors for the acquisition
of STD's between May, 1999, and September, 2001. They
were predominantly African-American (85%) ranging in
age from 14 to 17. Having a sexually transmitted disease
was not a prerequisite for enrolment but 84% of the
cohort were sexually active at the time of testing. Informed
consent was obtained from all participants as well as per-
mission from the accompanying parent/guardian for
entry into the study. Specimens were collected at the clin-
ics in Indianapolis and were subsequently shipped over-
night using cold packs to LSUHSC where they were
processed and analyzed.
In New Orleans healthy women between the ages of 18–
55 were enrolled into a study of the immune response to
Candida albicans vaginitis through the Obstetrics and
Gynecology Clinic at the Louisiana State University
Health Sciences Center (LSUHSC), New Orleans, Louisi-
ana. HIV infected and pregnant women were not eligible
for participation in the study. The specimens used in this
study were obtained prior to inoculation of C. albicans. All
clinical research protocols were reviewed and approved by
either or both of the Institutional Review Boards at Loui-
siana State University Health Sciences Centre (LSUHSC),
New Orleans, LA, and Indiana University/Purdue Univer-
sity at Indianapolis, Indianapolis, IN.
Specimen collection and processing
Specimens collected from enrolled subjects at both study
sites consisted of two vaginal swabs followed by a vaginal
lavage. One of the swabs was rolled onto a glass slide, air
dried and then Gram stained for the microscopic assess-
ment of BV using the Nugent criteria (0–3: normal, 4–6:
intermediate and 7–10: BV) [35]. A vaginal lavage was col-
lected by washing the vaginal vault for 30 to 40 seconds
using a syringe and 5 ml of non-pyrogenic sterile saline.
One half ml was placed in a sterile vial and frozen at -
70°C until thawed for DNA extraction.
Vaginal cultures
A 0.5 ml aliquot of vaginal washes were collected in BBL
Port-a-Cul vials from New Orleans women only. The sam-
ples were aseptically aspirated from the vial and then
plated in a manner allowing quantitation of the most
common organisms. Details of the media used and cul-
ture methods are available [see Additional file 1]. Colony
types present in the highest concentrations were purified
and identified using RapID ANA II System (Remel, Inc.,
Lenexa, KS) and API 20E (bioMerieux, Inc., Durham, NC)Page 2 of 8
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ATCC and propagated following ATCC instructions.
Susceptibility testing of Atopobium strains
A. vaginae strains were tested for susceptibility to various
antimicrobials using an NCCLS recommended broth
microdilution method for anaerobic bacteria (NCCLS,
M11-A5, 2001). Serial two-fold dilutions (0.05–256 µg/
ml) of each antimicrobial were prepared in Brucella broth
supplemented with vitamin K (1 µg/ml), hemin (5 µg/
ml), and laked horse blood (5%). Ampicillin and sul-
bactam were combined in a 2:1 ratio. The inoculum for
each isolate was prepared in pre-reduced Brucella broth by
suspending each isolate to turbidity equal to a no. 1 Mac-
Farland and further diluted to give a final inoculum size
of 105 CFU per well (106 CFU/ml). Prior to inoculation all
susceptibility plates were pre-reduced in an anaerobic
environment for 4–5 hours. Inoculated plates were incu-
bated anaerobically for 48 hours and read. The MIC end-
point was defined as the lowest concentration of each
antimicrobial which inhibited the visible growth of the
test isolate. Quality assurance was performed using B. fra-
gilis ATCC 25285 and B. thetaiotaomicron ATCC 29741.
DNA isolation
Approximately 0.5 ml of vaginal lavage fluid was used to
isolate bacterial DNA. Samples were pelleted in a table-
top micro centrifuge (5 min, 16,000 rpm) and the mate-
rial was suspended in ~600 µl of phosphate buffer (pH
7.5). Cells were lysed by bead beating and nucleic acids
were isolated as previously described [36].
PCR/DGGE/Sequence Analysis
Details of PCR primers were discussed previously [21].
One primer complements a region of the 16S rRNA gene
conserved among members of the domain Bacteria
(Escherichia coli positions 1055 to 1070; 5'-ATGGCT-
GTCGTCAGCT-3'). The other primer is based on a univer-
sally conserved region (E. coli positions 1392 to 1406)
and incorporates a 40-base GC clamp (5'-
CGCCCGCCGCGCCCCGCGCCCGGCCCGCCGCCCCC
GCCCCACGGGCGGTGTGTAC-3'). PCR conditions were
as follows: denaturation at 95°C for 5 min, followed by
25 cycles of 95°C for 1 min, 55°C for 1 min, 72°C for 1
min with a final extension at 72 C for 7 min. All DGGE
analyses were performed using a D-Code System along
with accessories and reagents essentially as described by
the manufacturer (Bio-Rad, Hercules, CA). Gels were 6%
acrylamide, gradients were 20 to 80% UF (100% UF
denaturant solution is 7 M urea, 40% deionized forma-
mide). Gel spacers were 1.0 mm, glass plates were 16 cm
high × 22 cm wide, loading wells were 1 cm wide. Denat-
urant gradients were formed using a model EP-1 peristal-
tic pump (Bio-Rad) at a flow rate of 5.0 ml/min and a
model GM-20 gradient maker (CBS Scientific, Del Mar,
CA). DGGE was run at 60°C at 70 V for 17 hrs. Gels were
stained with ethidium bromide and imaged with a Gel-
Doc system (Bio-Rad). DGGE bands were purified for
sequencing by repeated transfer, PCR amplification and
DGGE analysis as previously described [36].
Sequencing was performed by the LSUHSC genomics core
facility. Raw sequence data were aligned and edited using
Sequencher 3.1.1 software (Gene Codes Corporation,
Ann Arbor, MI) and compared to sequences in public
databases using BLAST [37].
Results
DGGE banding patterns of normal and BV positive samples
Lavage samples were obtained from 24 patients with nor-
mal vaginal secretion Gram stains, from two patients with
intermediate vaginal flora and from 20 with BV based on
Nugent's score. Two distinct types of banding patterns
were observed. The first, designated the normal type, con-
tained from 1 to 4 bands that were concentrated in the
centre region of the gradient gels (Fig. 1B). The sequences
of these bands were consistently those of Lactobacillus
spp., mainly L. crispatus and L. jensenii. When a patient's
vaginal flora was normal by Nugent's score, their DGGE
pattern was the normal type in 92% (22/24) of cases. A
second commonly observed DGGE pattern was desig-
nated the BV type, unlike the normal type these patterns
contained bands that were not all focused in the center
region of the gel and often contained more than 4 bands
(Fig. 1A). In addition to A. vaginae (see below) sequences
from bands in the BV gels included Gardnerella vaginalis,
Bifidobacterium spp. Mycoplasma sp. Prevotella sp. and
Lactobacillus sp. We did not sequence all bands in this
study. In all 22 patients with either intermediate vaginal
flora or BV by Nugent's Gram stain score, their DGGE pat-
tern was the BV type.
Examples of DGGE banding patterns obtained from 16S
rRNA gene segments PCR-amplified from nucleic acids
isolated from vaginal lavage samples of patients clinically
described as having BV-positive (A) or normal (B) vaginal
flora. The boxed area encloses examples of A. vaginae
bands. These were found in 55% of BV-positive samples.
Identification of A. vaginae by DGGE
We observed that two DGGE bands which migrated to
nearly the same position in the lower region of DGGE gels
were common in vaginal samples of BV-positive patients
but were not common in normal patients (Fig. 1 and 2,
boxed areas). Of the 14 patients whose DGGE patterns
contained these bands, seven contained both bands. The
boxed areas in Figure 2 provide an example of the double
band pattern. (Fig. 2A lane 1 and 2B lane 1). The 16S
rRNA sequences of two of the upper bands and five of the
lower bands were determined; all were A. vaginae. ThePage 3 of 8
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position in the gradient gel (for example Fig. 2A, lane 2
and Fig. 2B, lane 3) were exactly the same as that of A.
vaginae (GenBank reference no. AF 325325) while bands
that migrated to the slightly lower position (for example
Fig. 2A lane 3 and Fig. 2B lane 2) differed from A. vaginae
AF325325 by one nucleotide (a G instead of an A at nucle-
otide 1220 of A. vaginae GenBank reference AF325325).
Normal vs. BV positive DGGE banding patternsFigure 1
Normal vs. BV positive DGGE banding patterns 
Examples of DGGE banding patterns obtained from 16S 
rRNA gene segments PCR-amplified from nucleic acids iso-
lated from vaginal lavage samples of patients clinically 
described as having BV-positive (A) or normal (B) vaginal 
flora. The boxed area encloses examples of A. vaginae bands. 
These were found in 55% of BV-positive samples.
Identification of two A. vaginae strains by DGGE using PCR amplified segments of the 16S rRNA geneFigur  2
Identification of two A. vaginae strains by DGGE 
using PCR amplified segments of the 16S rRNA gene 
Panel A, lane 1 is from vaginal lavage sample #7189A 
obtained from a patient with BV. Note the closely opposed A. 
vaginae bands in the boxed area. Lanes 2 and 3 show the indi-
vidual A. vaginae bands from the same sample after extraction 
and re-amplification of the two bands in lane 1. Panel B, lane 
1 is from a vaginal lavage sample #7200A obtained from 
another BV positive patient #7200. It also shows the double 
A. vaginae band pattern (boxed area). Lane 2 shows the band 
obtained from an A. vaginae strain isolated from patient 
#7200. This band co-migrates with the lower of the two 
bands obtained from this patient's vaginal lavage sample. Lane 
3 shows the band obtained from the ATCC A. vaginae culture 
collection strain. It co-migrates with the upper of the two A. 
vaginae bands shown in lane 1. The slight difference in the 
electrophoretic migration of the A. vaginae bands correlates 
with a single nucleotide difference in their amplicons.Page 4 of 8
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DGGE analysis is only ~300 nucleotides, it includes a
highly variable region of the molecule [21] and the
sequences did not match other (non-A. vaginae) 16S rRNA
sequences in BLAST analyses [37]. Based on the presence
of bands at the appropriate position in denaturing gradi-
ent gels (illustrated by the boxed area in Figures 1 and 2),
55% (12/20) of BV positive samples contained A. vaginae,
as opposed to 8.3% (2/24) of normal samples (P < 0.001
by Chi Square). In the two cases where A. vaginae bands
were present in patients with "normal" vaginal secretions,
both exhibited complex (BV-like) DGGE patterns (data
not shown).
A. vaginae culture identification and antibiotic 
susceptibility
The A. vaginae ATTC strain (GenBank reference No.
AF325325) isolated from a women with a tubo-ovarian
abscess was reported to have coded out as Gemella morbil-
lorum using the API ID32A system. [34]. We reviewed our
vaginal culture results and found two cases (7193 and
7200) in which cultivated isolates were identified as G.
morbillorum using the RapID ANA II system. The vaginal
lavage fluid DGGE pattern from these two patients con-
tained bands identified as A. vaginae. These bacteria grew
only under anaerobic conditions as tiny grayish non-
hemolytic colonies. Gram stains revealed small Gram pos-
itive cocco-bacilli. These two isolates were passed to
assure purity and then subjected to DNA extraction, PCR-
amplification and DGGE analysis. The strain from patient
7200 contained a single dominant band that corre-
sponded to the lower of the two A. vaginae bands observed
in BV-positive patients (Fig. 2B lane 2). Despite having
been grown from a single colony, the strain from patient
7193 contained both A. vaginae bands in its DGGE pattern
(data not shown). Sequencing confirmed that one of these
bands was identical to the GenBank A. vaginae AF 325325
sequence while the other had the single nucleotide change
described above. It may be that the 7193 strain is not
axenic, alternatively, the strain may contain both copies of
the 16S rRNA gene [38-43]. Antibiotic susceptibility of
our two A. vaginae isolates and the ATCC type strain are
summarized in Table 1. Though all three organisms were
susceptible to most of the antibiotics tested they were
highly resistant to metronidazole.
Discussion
The genus Atopobium was proposed in 1992 [44] to
accommodate bacterial isolates previously classified as
Lactobacillus minitus, L. rimae and Streptococcus parvulus.
The species A. vaginae (GenBank accession no. Y17195)
was defined in 1999 from a vaginal isolate of a "healthy
patient" though no description of the nature of vaginal
flora in this patient was given [33]. More recently, A. vagi-
nae (GenBank accession no. AF325325) was reported as
the infective agent in a tuboovarian abscess [34]. The 16S
rRNA gene sequences of Y17195 and AF32325 are indis-
tinguishable though there are four undefined nucleotides
in the sequence of the former.
This is the first report of the association of A. vaginae with
abnormal vaginal flora. The appearance of prominent A.
vaginae bands in 55% of patients with Nugent scores >3
suggests that the species was prominent in patients with
abnormal vaginal secretions. The presence of A. vaginae
DGGE bands in only 8.3% of samples from patients with
normal flora suggests that A. vaginae was not prominent
in normal vaginal secretions. It is unlikely that the fre-
quency of the A. vaginae bands in BV-positive samples,
and their absence from normal samples, is an artifact of
the PCR amplification/DGGE method. The PCR primers
complement sites on both Lactobacillus spp. and A. vaginae
16S rRNA genes, and A. vaginae and Lactobacillus bands co-
occur in some specimens (Fig. 1). Thus there is no evi-
Table 1: Antibiotic susceptibility. MIC values (µg/ml) determined by NCCLS broth microdilution of Atopobium isolates to various 
antimicrobial agents.
ATCC BAA55 DM7193 DM7200
Metronidazole >32 >32 >32
Clindamycin <0.015 <0.015 <0.015
Ceftriaxone 2 0.5 .5
Cefoxitin 2 2 2
Ampicillin/sulb 0.25 0.25 .06
Meropenem 0.5 0.03 <0.015
Imipenem 0.5 0.03 <0.015
Moxifloxacin 0.12 0.06 1
Trovafloxacin 0.03 <0.015 2
Linezolid 0.25 .25 .06
Disk Tests
Aminoglycosides* R R R
Vancomycin* S S S
*done by disk diffusion as a screening testPage 5 of 8
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explain the lack of A. vaginae bands in DGGE patterns of
normal patients. The appearance of prominent A. vaginae
bands in DGGE patterns of BV-positive patients is likely a
true reflection of their prevalence in the bacterial ecology
that constitutes the BV syndrome.
In some cases complex (BV-like) DGGE patterns were
obtained from patients with normal vaginal secretion
Gram stains. In fact this was the case in both samples that
were normal by Nugent's criteria but also produced A.
vaginae bands by DGGE analysis. There are almost cer-
tainly instances when vaginal flora cannot adequately be
classified as normal or BV positive using the current crite-
ria [45]. We noted an array of DGGE patterns among
patients diagnosed with BV. (Fig. 1A). These PCR-gener-
ated patterns provided a more objective and informative
assessment of vaginal flora than standard clinical and/or
Gram stain criteria. The ability to more fully resolve vagi-
nal flora into patterns using DGGE, combined with the
ability to correlate these patterns with bacterial species
and aspects of disease, such as onset, progression or
response to antibiotics, could lead to a better understand-
ing of the BV syndrome [12,27,28].
As part of our evaluation of the potential role of DGGE in
assessing vaginal flora we had evaluated a series of
patients using quantitative culture techniques. The details
of this evaluation will be the subject of a future publica-
tion. After detecting A. vaginae using molecular tech-
niques, we reviewed our culture results to determine if any
of our isolates had been identified as G. morbillorum,
based on the report by Geissdorfer et al. [34] that their A.
vaginae isolate was originally misclassified as this organ-
ism by the API ID32A system. We found that two of our
isolates had been identified as G morbillorum using the
RapID ANA II system. As did Geissdorfer et al., we found
that our isolates were actually A. vaginae based on 16S
rRNA gene sequencing and both proved to be strict anaer-
obes as was theirs. Of note is the fact that despite the orig-
inal description of A. vaginae as a facultative anaerobe by
Rodriquez Jovita et al [33] we found it to be a strict anaer-
obe using the type strain submitted to ATCC by these
investigators. The reason for this discrepancy is unclear
but the weight of evidence thus far indicates that A. vagi-
nae is a strict anaerobe.
It is not surprising that A. vaginae has not been previously
recognized in women with BV. The Gram stain appear-
ance is that of a small Gram positive cocco-bacillus and
members of the genus are known to produce large
amounts of lactic acid. On this basis, some species belong-
ing to the genus Atopobium were originally identified as
Lactobacillus sp. In fact it was in the course of a study of
vaginal lactobacilli that A. vaginae was originally identi-
fied [33]. To our knowledge G morbillorum has not been
reported in previous descriptions of normal or abnormal
vaginal flora. Differences between bacteriologic methods
could explain this discrepancy. It may be that some iden-
tification systems do not correctly separate anaerobic
lactobacilli and streptococci from A. vaginae.
A potentially important observation is that A. vaginae
appears to be highly metronidazole resistant. We have
extended the observation of Geissdorfer et al [34] who
first described metronidazole resistance in this species
using their strain. Our two isolates and the originally
described type strain are highly metronidazole resistant.
Therefore, as all four known A. vaginae isolates are metro-
nidazole resistant, this may be a characteristic of this spe-
cies. Additional testing of new isolates will be required to
confirm this possibility. Geissdorfer et al [34] reported
their strain to be susceptible to penicillin, cefuroxime,
cefoxitin and impenem. We found the organisms to be
susceptible to clindamycin, cephalosporins, carbapen-
ems, ampicillin/sulbactam and linezolid and were moder-
ately susceptible to the quinolones. (Table 1). By disc
diffusion our strains were resistant to gentamicin but sus-
ceptible to vancomycin. It is interesting to speculate that
this organism could possibly contribute to BV treatment
failures or relapses which are common [2]. Prospective
treatment studies are needed to determine whether or not
A. vaginae and other metronidazole resistant organisms
such as Mobiluncus curtisii might play such a role.
Conclusions
DGGE ananysis of segments of PCR-amplified 16S rRNA
gene sequences appears to be a useful tool in describing
the complex bacterial flora associated with BV, and rela-
tively simple flora associated with normal vaginal envi-
ronments. Our observations require confirmation in
other populations of women, but it appears that A. vagi-
nae may be a common component of the microbial flora
associated with BV. A. vaginae would likely not be effec-
tively cleared using metronidazole, the most common
antibiotic used to treat BV. Further prospective treatment
studies should be undertaken to elucidate the possible sig-
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